_id
691092f7ccc777a4e85d5a1f
Ticker
EAPIF
Name
Euroapi S.A
Exchange
PINK
Address
15 Rue Traversiere, Paris, France, 75012
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.euroapi.com/en
Description
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances. It provides their products to pharmaceutical, generic drug manufacturers, animal health product manufacturers, consumer health, nutrition and cosmetic product companies, biotech companies, and distribution companies, as well as contract development and manufacturing organization. The company has a strategic alliance with Abolis Biotechnologies SAS for the development of microbial strains for the synthesis of key intermediates and 20 active ingredients. Euroapi S.A. was incorporated in 2020 and is based in Paris, France.
Last Close
3.7
Volume
2800
Current Price
2.63
Change
0
Last Updated
2026-01-02T13:00:00.922Z
Image
-
Ipo Date
-
Market Cap
273412800
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9385
Sentiment Sources
2
Current Quarter
2025-06-30
Revenue
414500000
Cost Of Revenue
337900000
Gross Profit
76600000
Operating Expenses
104400000
Operating Income
-27800000
Interest Expense
1600000
Pretax Income
-30000000
Net Income
-28500000
Eps
-0.30063291139240506
Dividends Per Share
-
Shares Outstanding
95213556
Income Tax Expense
1500000
EBITDA
35300000
Operating Margin
-6.706875753920386
Total Other Income Expense Net
-2200000
Cash
51500000
Short Term Investments
6300000
Receivables
156500000
Inventories
538400000
Total Current Assets
787000000
Property Plant Equipment
524900000
Total Assets
1441900000
Payables
111100000
Short Term Debt
54300000
Long Term Debt
-
Total Liabilities
488400000
Equity
953500000
Bs_currency_symbol
EUR
Depreciation
29300000
Change In Working Capital
6700000
Cash From Operations
18400000
Capital Expenditures
37800000
Cash From Investing
-38300000
Cash From Financing
-4000000
Net Change In Cash
51500000
Cf_currency_symbol
-
PE
-
PB
0.2614829575249082
ROE
-2.9889879391714733
ROA
-1.9765587072612525
FCF
-19400000
Fcf Percent
-0.046803377563329314
Piotroski FScore
2
Health Score
31
Deep Value Investing Score
5.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
4.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
414500000
Quarters > 0 > income Statement > cost Of Revenue
337900000
Quarters > 0 > income Statement > gross Profit
76600000
Quarters > 0 > income Statement > operating Expenses
104400000
Quarters > 0 > income Statement > operating Income
-27800000
Quarters > 0 > income Statement > interest Expense
1600000
Quarters > 0 > income Statement > pretax Income
-30000000
Quarters > 0 > income Statement > net Income
-28500000
Quarters > 0 > income Statement > eps
-0.30063291139240506
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
94800000
Quarters > 0 > income Statement > income Tax Expense
1500000
Quarters > 0 > income Statement > EBITDA
35300000
Quarters > 0 > income Statement > operating Margin
-6.706875753920386
Quarters > 0 > income Statement > total Other Income Expense Net
-2200000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
51500000
Quarters > 0 > balance Sheet > short Term Investments
6300000
Quarters > 0 > balance Sheet > receivables
156500000
Quarters > 0 > balance Sheet > inventories
538400000
Quarters > 0 > balance Sheet > total Current Assets
787000000
Quarters > 0 > balance Sheet > property Plant Equipment
524900000
Quarters > 0 > balance Sheet > total Assets
1441900000
Quarters > 0 > balance Sheet > payables
111100000
Quarters > 0 > balance Sheet > short Term Debt
54300000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
488400000
Quarters > 0 > balance Sheet > equity
953500000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-28500000
Quarters > 0 > cash Flow > depreciation
29300000
Quarters > 0 > cash Flow > change In Working Capital
6700000
Quarters > 0 > cash Flow > cash From Operations
18400000
Quarters > 0 > cash Flow > capital Expenditures
37800000
Quarters > 0 > cash Flow > cash From Investing
-38300000
Quarters > 0 > cash Flow > cash From Financing
-4000000
Quarters > 0 > cash Flow > net Change In Cash
51500000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.30063291139240506
Quarters > 0 > ratios > PB
0.2614829575249082
Quarters > 0 > ratios > ROE
-2.9889879391714733
Quarters > 0 > ratios > ROA
-1.9765587072612525
Quarters > 0 > ratios > FCF
-19400000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.046803377563329314
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
468300000
Quarters > 1 > income Statement > cost Of Revenue
423900000
Quarters > 1 > income Statement > gross Profit
44400000
Quarters > 1 > income Statement > operating Expenses
131400000
Quarters > 1 > income Statement > operating Income
-87000000
Quarters > 1 > income Statement > interest Expense
5700000
Quarters > 1 > income Statement > pretax Income
-98100000
Quarters > 1 > income Statement > net Income
-95800000
Quarters > 1 > income Statement > eps
-1.0126849894291754
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
94600000
Quarters > 1 > income Statement > income Tax Expense
-2300000
Quarters > 1 > income Statement > EBITDA
-77400000
Quarters > 1 > income Statement > operating Margin
-18.57783472133248
Quarters > 1 > income Statement > total Other Income Expense Net
-11100000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
73000000
Quarters > 1 > balance Sheet > short Term Investments
6200000
Quarters > 1 > balance Sheet > receivables
161300000
Quarters > 1 > balance Sheet > inventories
524200000
Quarters > 1 > balance Sheet > total Current Assets
830300000
Quarters > 1 > balance Sheet > property Plant Equipment
529300000
Quarters > 1 > balance Sheet > total Assets
1489500000
Quarters > 1 > balance Sheet > payables
104900000
Quarters > 1 > balance Sheet > short Term Debt
55900000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
506000000
Quarters > 1 > balance Sheet > equity
983500000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-95800000
Quarters > 1 > cash Flow > depreciation
44800000
Quarters > 1 > cash Flow > change In Working Capital
73400000
Quarters > 1 > cash Flow > cash From Operations
51700000
Quarters > 1 > cash Flow > capital Expenditures
46700000
Quarters > 1 > cash Flow > cash From Investing
-46700000
Quarters > 1 > cash Flow > cash From Financing
-212300000
Quarters > 1 > cash Flow > net Change In Cash
-207600000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-1.0126849894291754
Quarters > 1 > ratios > PB
0.25297203863751905
Quarters > 1 > ratios > ROE
-9.740721911540417
Quarters > 1 > ratios > ROA
-6.431688486069151
Quarters > 1 > ratios > FCF
5000000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.010676916506512918
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
450900000
Quarters > 2 > income Statement > cost Of Revenue
352900000
Quarters > 2 > income Statement > gross Profit
98000000
Quarters > 2 > income Statement > operating Expenses
131400000
Quarters > 2 > income Statement > operating Income
-33400000
Quarters > 2 > income Statement > interest Expense
22400000
Quarters > 2 > income Statement > pretax Income
-41500000
Quarters > 2 > income Statement > net Income
-34800000
Quarters > 2 > income Statement > eps
-0.36287799791449427
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
95900000
Quarters > 2 > income Statement > income Tax Expense
-6700000
Quarters > 2 > income Statement > EBITDA
42700000
Quarters > 2 > income Statement > operating Margin
-7.4074074074074066
Quarters > 2 > income Statement > total Other Income Expense Net
-8100000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
282800000
Quarters > 2 > balance Sheet > short Term Investments
7400000
Quarters > 2 > balance Sheet > receivables
176700000
Quarters > 2 > balance Sheet > inventories
638700000
Quarters > 2 > balance Sheet > total Current Assets
1155800000
Quarters > 2 > balance Sheet > property Plant Equipment
504300000
Quarters > 2 > balance Sheet > total Assets
1795900000
Quarters > 2 > balance Sheet > payables
143600000
Quarters > 2 > balance Sheet > short Term Debt
457100000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
906300000
Quarters > 2 > balance Sheet > equity
889600000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-34800000
Quarters > 2 > cash Flow > depreciation
32000000
Quarters > 2 > cash Flow > change In Working Capital
82399998
Quarters > 2 > cash Flow > cash From Operations
71200000
Quarters > 2 > cash Flow > capital Expenditures
61300000
Quarters > 2 > cash Flow > cash From Investing
-61300000
Quarters > 2 > cash Flow > cash From Financing
238800000
Quarters > 2 > cash Flow > net Change In Cash
282800000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.36287799791449427
Quarters > 2 > ratios > PB
0.28351731115107914
Quarters > 2 > ratios > ROE
-3.911870503597122
Quarters > 2 > ratios > ROA
-1.9377470905952445
Quarters > 2 > ratios > FCF
9900000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.021956087824351298
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
225450000
Quarters > 3 > income Statement > cost Of Revenue
176450000
Quarters > 3 > income Statement > gross Profit
49000000
Quarters > 3 > income Statement > operating Expenses
65700000
Quarters > 3 > income Statement > operating Income
10050000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-20750000
Quarters > 3 > income Statement > net Income
-17400000
Quarters > 3 > income Statement > eps
-0.18451749734888653
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
94300000
Quarters > 3 > income Statement > income Tax Expense
3350000
Quarters > 3 > income Statement > EBITDA
26050000
Quarters > 3 > income Statement > operating Margin
4.45775116433799
Quarters > 3 > income Statement > total Other Income Expense Net
-30800000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
282800000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
176700000
Quarters > 3 > balance Sheet > inventories
638700000
Quarters > 3 > balance Sheet > total Current Assets
1155800000
Quarters > 3 > balance Sheet > property Plant Equipment
504200000
Quarters > 3 > balance Sheet > total Assets
1795900000
Quarters > 3 > balance Sheet > payables
143600000
Quarters > 3 > balance Sheet > short Term Debt
457100000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
906400000
Quarters > 3 > balance Sheet > equity
889500000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-17400000
Quarters > 3 > cash Flow > depreciation
16000000
Quarters > 3 > cash Flow > change In Working Capital
41199999
Quarters > 3 > cash Flow > cash From Operations
35600000
Quarters > 3 > cash Flow > capital Expenditures
30650000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
119400000
Quarters > 3 > cash Flow > net Change In Cash
124100000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.18451749734888653
Quarters > 3 > ratios > PB
0.27881843732433953
Quarters > 3 > ratios > ROE
-1.9561551433389546
Quarters > 3 > ratios > ROA
-0.9688735452976223
Quarters > 3 > ratios > FCF
4950000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.021956087824351298
Quarters > 3 > health Score
25
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
919200000
Annuals > 0 > income Statement > cost Of Revenue
776800000
Annuals > 0 > income Statement > gross Profit
142400000
Annuals > 0 > income Statement > operating Expenses
262800000
Annuals > 0 > income Statement > operating Income
-120400000
Annuals > 0 > income Statement > interest Expense
28100000
Annuals > 0 > income Statement > pretax Income
-139600000
Annuals > 0 > income Statement > net Income
-130600000
Annuals > 0 > income Statement > eps
-1.3805496828752644
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
94600000
Annuals > 0 > income Statement > income Tax Expense
-9000000
Annuals > 0 > income Statement > EBITDA
-34700000
Annuals > 0 > income Statement > operating Margin
-13.09834638816362
Annuals > 0 > income Statement > total Other Income Expense Net
-19200000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
73000000
Annuals > 0 > balance Sheet > short Term Investments
6200000
Annuals > 0 > balance Sheet > receivables
161300000
Annuals > 0 > balance Sheet > inventories
524200000
Annuals > 0 > balance Sheet > total Current Assets
830300000
Annuals > 0 > balance Sheet > property Plant Equipment
529300000
Annuals > 0 > balance Sheet > total Assets
1489500000
Annuals > 0 > balance Sheet > payables
104900000
Annuals > 0 > balance Sheet > short Term Debt
55900000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
506000000
Annuals > 0 > balance Sheet > equity
983500000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-130600000
Annuals > 0 > cash Flow > depreciation
76800000
Annuals > 0 > cash Flow > change In Working Capital
155800000
Annuals > 0 > cash Flow > cash From Operations
122900000
Annuals > 0 > cash Flow > capital Expenditures
108000000
Annuals > 0 > cash Flow > cash From Investing
-108000000
Annuals > 0 > cash Flow > cash From Financing
26500000
Annuals > 0 > cash Flow > net Change In Cash
40700000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-1.3805496828752644
Annuals > 0 > ratios > PB
0.25297203863751905
Annuals > 0 > ratios > ROE
-13.279105236400609
Annuals > 0 > ratios > ROA
-8.768042967438738
Annuals > 0 > ratios > FCF
14900000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.016209747606614446
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1018900000
Annuals > 1 > income Statement > cost Of Revenue
854300000
Annuals > 1 > income Statement > gross Profit
164600000
Annuals > 1 > income Statement > operating Expenses
398900000
Annuals > 1 > income Statement > operating Income
-234300000
Annuals > 1 > income Statement > interest Expense
10900000
Annuals > 1 > income Statement > pretax Income
-242700000
Annuals > 1 > income Statement > net Income
-189700000
Annuals > 1 > income Statement > eps
-2.01380042462845
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
94200000
Annuals > 1 > income Statement > income Tax Expense
-53000000
Annuals > 1 > income Statement > EBITDA
71100000
Annuals > 1 > income Statement > operating Margin
-22.99538718225537
Annuals > 1 > income Statement > total Other Income Expense Net
-8400000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
34500000
Annuals > 1 > balance Sheet > short Term Investments
8400000
Annuals > 1 > balance Sheet > receivables
234000000
Annuals > 1 > balance Sheet > inventories
644800000
Annuals > 1 > balance Sheet > total Current Assets
979300000
Annuals > 1 > balance Sheet > property Plant Equipment
506200000
Annuals > 1 > balance Sheet > total Assets
1612400000
Annuals > 1 > balance Sheet > payables
159600000
Annuals > 1 > balance Sheet > short Term Debt
210000000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
684600000
Annuals > 1 > balance Sheet > equity
927800000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-189700000
Annuals > 1 > cash Flow > depreciation
302900000
Annuals > 1 > cash Flow > change In Working Capital
-68700000
Annuals > 1 > cash Flow > cash From Operations
5100000
Annuals > 1 > cash Flow > capital Expenditures
132800000
Annuals > 1 > cash Flow > cash From Investing
-137300000
Annuals > 1 > cash Flow > cash From Financing
92200000
Annuals > 1 > cash Flow > net Change In Cash
-40000000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-2.01380042462845
Annuals > 1 > ratios > PB
0.2670252209527915
Annuals > 1 > ratios > ROE
-20.446216857081268
Annuals > 1 > ratios > ROA
-11.765070702059042
Annuals > 1 > ratios > FCF
-127700000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.12533123957208755
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
980900000
Annuals > 2 > income Statement > cost Of Revenue
804000000
Annuals > 2 > income Statement > gross Profit
176900000
Annuals > 2 > income Statement > operating Expenses
177700000
Annuals > 2 > income Statement > operating Income
-800000
Annuals > 2 > income Statement > interest Expense
4200000
Annuals > 2 > income Statement > pretax Income
3200000
Annuals > 2 > income Statement > net Income
-15000000
Annuals > 2 > income Statement > eps
-0.15879486805898502
Annuals > 2 > income Statement > dividends Per Share
98500000
Annuals > 2 > income Statement > shares Outstanding
94461491
Annuals > 2 > income Statement > income Tax Expense
18200000
Annuals > 2 > income Statement > EBITDA
120200000
Annuals > 2 > income Statement > operating Margin
-0.08155775308390253
Annuals > 2 > income Statement > total Other Income Expense Net
4000000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
74500000
Annuals > 2 > balance Sheet > short Term Investments
4800000
Annuals > 2 > balance Sheet > receivables
270600000
Annuals > 2 > balance Sheet > inventories
594700000
Annuals > 2 > balance Sheet > total Current Assets
1023600000
Annuals > 2 > balance Sheet > property Plant Equipment
639300000
Annuals > 2 > balance Sheet > total Assets
1736100000
Annuals > 2 > balance Sheet > payables
219600000
Annuals > 2 > balance Sheet > short Term Debt
104600000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
625900000
Annuals > 2 > balance Sheet > equity
1110200000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-15000000
Annuals > 2 > cash Flow > depreciation
94500000
Annuals > 2 > cash Flow > change In Working Capital
-66400000
Annuals > 2 > cash Flow > cash From Operations
44800000
Annuals > 2 > cash Flow > capital Expenditures
167400000
Annuals > 2 > cash Flow > cash From Investing
-167400000
Annuals > 2 > cash Flow > cash From Financing
187800000
Annuals > 2 > cash Flow > net Change In Cash
64200000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.15879486805898502
Annuals > 2 > ratios > PB
0.22377384374887407
Annuals > 2 > ratios > ROE
-1.3511079084849578
Annuals > 2 > ratios > ROA
-0.8640055296353897
Annuals > 2 > ratios > FCF
-122600000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.12498725660108063
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
892800000
Annuals > 3 > income Statement > cost Of Revenue
783700000
Annuals > 3 > income Statement > gross Profit
109100000
Annuals > 3 > income Statement > operating Expenses
121900000
Annuals > 3 > income Statement > operating Income
-12800000
Annuals > 3 > income Statement > interest Expense
2100000
Annuals > 3 > income Statement > pretax Income
-14600000
Annuals > 3 > income Statement > net Income
-8100000
Annuals > 3 > income Statement > eps
-0.08614557146674896
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
94026888
Annuals > 3 > income Statement > income Tax Expense
-6500000
Annuals > 3 > income Statement > EBITDA
63500000
Annuals > 3 > income Statement > operating Margin
-1.4336917562724014
Annuals > 3 > income Statement > total Other Income Expense Net
-1800000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
10300000
Annuals > 3 > balance Sheet > short Term Investments
19000000
Annuals > 3 > balance Sheet > receivables
250000000
Annuals > 3 > balance Sheet > inventories
569500000
Annuals > 3 > balance Sheet > total Current Assets
905000000
Annuals > 3 > balance Sheet > property Plant Equipment
631800000
Annuals > 3 > balance Sheet > total Assets
1618500000
Annuals > 3 > balance Sheet > payables
189600000
Annuals > 3 > balance Sheet > short Term Debt
5400000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
607000000
Annuals > 3 > balance Sheet > equity
1011500000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-15800000
Annuals > 3 > cash Flow > depreciation
76000000
Annuals > 3 > cash Flow > change In Working Capital
9800000
Annuals > 3 > cash Flow > cash From Operations
71500000
Annuals > 3 > cash Flow > capital Expenditures
88600000
Annuals > 3 > cash Flow > cash From Investing
-87900000
Annuals > 3 > cash Flow > cash From Financing
26500000
Annuals > 3 > cash Flow > net Change In Cash
10200000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.08614557146674896
Annuals > 3 > ratios > PB
0.24447920458724665
Annuals > 3 > ratios > ROE
-0.800790904597133
Annuals > 3 > ratios > ROA
-0.5004633920296572
Annuals > 3 > ratios > FCF
-17100000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.019153225806451613
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.30063291139240506
Valuation > metrics > PB
0.2614829575249082
Valuation > final Score
70
Valuation > verdict
73.9% Undervalued
Profitability > metrics > ROE
-2.9889879391714733
Profitability > metrics > ROA
-3.6213468869123253
Profitability > metrics > Net Margin
-0.06875753920386007
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5122181436811746
Risk > metrics > Interest Coverage
-17.375
Risk > final Score
-21
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.758162031438936
Liquidity > metrics > Quick Ratio
1.5030229746070134
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-13
Prev Risks > 1
24
Prev Risks > 2
31
Prev Liquidities > 0
100
Prev Liquidities > 1
91
Prev Liquidities > 2
91
Updated At
2026-01-20T21:44:43.704Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-03
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances. It provides their products to pharmaceutical, generic drug manufacturers, animal health product manufacturers, consumer health, nutrition and cosmetic product companies, biotech companies, and distribution companies, as well as contract development and manufacturing organization. The company has a strategic alliance with Abolis Biotechnologies SAS for the development of microbial strains for the synthesis of key intermediates and 20 active ingredients. Euroapi S.A. was incorporated in 2020 and is based in Paris, France.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AEuroapi: Public Financing, Reorganization, And Very Cheap (OTCMKTS:EAPIF) Seeking Alpha
Read more →(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Euroapi S.A
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.